Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
100 participants
INTERVENTIONAL
2025-08-15
2025-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
KinesioTaping (KT), a method originally developed for musculoskeletal conditions, involves the application of elastic therapeutic tape to the skin with the aim of supporting soft tissue structures, enhancing lymphatic and blood flow, and modulating nociceptive input via stimulation of cutaneous mechanoreceptors. In the context of postoperative care, KT may also help reduce localized edema, support incision sites, and promote a sense of physical stability that contributes to pain relief.
Despite its growing popularity in rehabilitation and sports medicine, the use of KinesioTaping in postoperative settings-particularly in cardiothoracic surgery-remains under-investigated. Limited studies have suggested potential benefits in reducing pain and improving functional outcomes, but current evidence is inconclusive and often methodologically limited.
This prospective, randomized controlled trial aims to evaluate the effectiveness of KinesioTaping when applied around mediastinal and thoracic drain sites in patients undergoing cardiac surgery. The primary objective is to assess postoperative pain levels using validated pain scales (e.g., VAS) in patients receiving KT versus those receiving standard care without taping. Secondary outcomes include opioid consumption, time to ambulation, respiratory function (spirometry or incentive spirometry use), incidence of atelectasis, and patient satisfaction scores.
By providing high-quality evidence on a low-cost, non-invasive, and easily applicable intervention, this study seeks to clarify the potential role of KinesioTaping as an adjunctive tool in postoperative pain management protocols following cardiac surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kinesiotaping group
In this group, KinesioTaping will be applied alongside routine pain management.
Kinesiotaping
In this group, KinesioTaping will be applied around the thoracic drain sites alongside standard analgesic therapy. This physical therapy technique uses elastic tapes placed on the skin to support healing, reduce pain, and improve patient comfort. The tapes will remain in place for 2-3 days and will be removed together with the drains.
Routine treatment group
This group will be managed with standard hospital-based painkiller administration.
Dexketoprofen, tramadol
Patients in this group will be treated with painkillers consisting of tramadol and dexketoprofen.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesiotaping
In this group, KinesioTaping will be applied around the thoracic drain sites alongside standard analgesic therapy. This physical therapy technique uses elastic tapes placed on the skin to support healing, reduce pain, and improve patient comfort. The tapes will remain in place for 2-3 days and will be removed together with the drains.
Dexketoprofen, tramadol
Patients in this group will be treated with painkillers consisting of tramadol and dexketoprofen.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are stable until the removal of the chest drain
* Patients who do not experience serious complications such as bleeding or neurological problems
Exclusion Criteria
* Patients with early post-cardiac surgery mortality,
* Patients with conditions requiring reoperation, such as bleeding,
* Patients for whom a pain score cannot be measured, such as neurological complications
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kastamonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İsmail DAL
Assistant Professor Literally: Doctor Teaching Member
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kastamonu Education and Research Hospital
Kastamonu, Kastamonu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KastamonuUnii
Identifier Type: -
Identifier Source: org_study_id